Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series

Aim: Long-term survivors (LTS) after glioma recurrence while on bevacizumab (Bev) therapy are rarely reported in the current literature. The purpose of this case series is to confirm the existence of and describe a large cohort of recurrent glioma LTS treated with Bev (Bev-LTS). Patients & metho...

Descrición completa

Detalles Bibliográficos
Main Authors: Liang Yen Liu, Matthew S Ji, Nhung T Nguyen, Frances E Chow, Donna M Molaie, Sean T Pianka, Richard M Green, Linda M Liau, Benjamin M Ellingson, Phioanh L Nghiemphu, Timothy F Cloughesy, Albert Lai
Formato: Artigo
Idioma:English
Publicado: Taylor & Francis Group 2019-06-01
Series:CNS Oncology
Subjects:
Acceso en liña:https://www.futuremedicine.com/doi/10.2217/cns-2019-0007